1.38“Field” means the oncology field, including therapeutic, palliative, prophylactic, diagnostic and research use, in human and animals.
1.39“FTE” means the equivalent of scientific, medical or technical, but for the avoidance of doubt not including financial, legal, marketing or business development, unless otherwise decided by the Steering Committee, work of one (1) person, directly and specifically conducting Development Activities, full time for one (1) year, which equates to a total of [***] hours annually. For the avoidance of doubt, such work may include, where appropriate, [***].
1.40“FTE Rate” means a rate of [***] per annum per FTE [***]. [***].
1.41“GAAP” means the then-current accounting practices of either Party, consisting of either (a) generally accepted accounting principles, or (b) the International Financial Reporting Standards (“IFRS”), as the case may be.
1.42“Governmental Authority” means any multinational, federal, state, local, municipal or other governmental authority of any nature (including any governmental association, division, prefecture, subdivision, department, agency, bureau, branch, office, commission, committee, council, court or other tribunal, such as statutory health insurance funds and their associations), in each case having jurisdiction over the applicable subject matter.
1.43“Improvements” means collectively Aptevo Manufacturing Improvements and Aptevo Platform Improvements.
1.44“Joint Know-How” means any Know-How (other than Aptevo Platform Know-How and Aptevo Manufacturing Know-How) conceived, generated or otherwise made during the course of conducting Development Activities, whether by employees, consultants or contractors of either Party (or both Parties) or their respective Affiliates or licensees, including Development Data.
1.45“Joint Patent” means any Patent claiming an invention or subject matter included in Joint Know-How.
1.46“Joint Technology” means Joint Patents and Joint Know-How.
1.47“Know-How” means any data, results, material(s), technology and non-public information of any type whatsoever, in any tangible or intangible form, including know-how, trade secrets, practices, techniques, methods, processes, inventions, developments, specifications, formulations, formulae, compositions of matter of any type (patentable or otherwise), software,
[*** ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.